Filing Details
- Accession Number:
- 0001415889-23-012474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-22 15:57:39
- Reporting Period:
- 2023-08-21
- Accepted Time:
- 2023-08-22 15:57:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1818844 | Virios Therapeutics Inc. | VIRI | Pharmaceutical Preparations (2834) | 854314201 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1826115 | William Pridgen | C/O Virios Therapeutics, Inc. 44 Milton Avenue Alpharetta GA 30009 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-21 | 15,335 | $1.30 | 52,045 | No | 4 | P | Indirect | 401 (k) Account |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | 401 (k) Account |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 709,234 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.26 to $1.36, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4.
- The number of shares reported are indirectly held within the Reporting Person's 401(k) account and are invested in the Tuscaloosa Surgical Assoc PC 401k U/A Dtd Jan 1, 2001 of which the Reporting Person is trustee.